Rivaroxaban
Indication
Treatment of deep vein thrombosis and prevention of recurrent DVT and pulmonary embolism (NICE TA261)
NICE TA261 - Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism
Amber level 0
Brand:
Xarelto®
Nice TA:
261
Commissioning responsibility:
CCG
PbR excluded:
No
BNF chapter:
Cardiovascular system
Background
Recommendation
LSCMMG Recommendation:
Amber level 0
Reason for decision:
Suitable for GP prescribing following recommendation/initiation by specialist
Supporting documents: